Cholesterol and ApoE in Alzheimer’s disease

• Main Authors: Potier Marie-Claude, Hanbouch Linda, Marquer Catherine
• Format: Article
• Language: English
• Published: EDP Sciences 2018-07-01
• Series: Oilseeds and fats, crops and lipids
• Subjects: Alzheimer’s disease; cholesterol; Apo lipoprotein E; endosome; amyloid
• Online Access: https://doi.org/10.1051/ocl/2018038

Genetic, neuropathological and biochemical studies suggest strong links between cholesterol, the apolipoprotein E (APOE) and Alzheimer’s disease (AD), both in humans and in animal models of the disease. From the literature and our work, we can predict that transient increase of the levels of cholesterol at the membrane of neurons would profoundly affect the processing of the transmembrane Amyloid Precursor Protein (APP) by triggering its clathrin dependent endocytosis and the resulting production of amyloid-β (Aβ) peptides. Here, we will review these data together with structural and molecular dynamic studies that characterized the role of cholesterol on APP conformation and positioning at the membrane. Specifically decreasing brain cholesterol or replacing it with plant sterols crossing the blood brain barrier appear like promising strategies to either delay or counteract the development of sporadic AD.